All stakeholders in patient advocacy, engagement, affairs, clinical trials, access and medical affairs are welcome to this year’s Global Innovation in Patient Advocacy conference, presented by Dynamic Global Events (“DGE”). The conference promises to empower global advocacy leaders to transcend patient partnerships, building on the success of last year’s Chief Patient Officer Summit held in July 2022 in Boston, MA.
This virtual event, scheduled for March 9-10, 2023, will cover topics such as tips for how to best assess the drug access infrastructure of specific regions, how to best identify the local landscape and map out stakeholders, including government officials, health care providers, patients and caregivers, and patient groups, plus understanding the differences in patient engagement practices in varying regions of the world. Other key topics will include:
- Characterizing differences in patient engagement practices around the world
- Understanding healthcare ecosystems and drug access infrastructures in varying regions
- Strengthening collaboration with global affiliates and across functions
- Growing capabilities for sustaining relationships with patient communities from pre-clinical through post-approval
The conference will feature a wide range of distinguished speakers, such as Thomas Bols, Head Of Government And Patient Advocacy, EMEA & APAC, PTC Therapeutics, Marie-Neith De Loisy, Patient Engagement Head – France, Novartis, and Helen Allvin, Global Patient Advocacy Lead, Orion Corporation, Orion Pharma.
Each speaker will offer a wealth of information on the critical topics for the event in the allotted 45-minute sessions, making it a perfect avenue for attendees to build on their knowledge of the various areas covered.
The breadth of this conference makes it ideal for those looking to learn how leaders in global patient advocacy and engagement thrive in ever-changing dynamic environments with external and internal collaborators. With a range of virtual sessions, attendees are guaranteed a platform where they can advance their knowledge and also network with other experts and individuals in their field.
To learn more, please visit https://ibn.fm/HCaKn.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.